Kush Parmar - Managing Partner @ 5AM Ventures

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

77,668

Primary Job Title Managing Partner
Primary Organization
5AM Ventures

Location Boston, Massachusetts, United States
Regions Greater Boston Area, East Coast, New England
Gender Male

Investor Type
obfuscated
obfuscation

Facebook View on Facebook
LinkedIn View on LinkedIn

Kush M. Parmar is based out of Boston, Massachusetts, and is the Managing Partner of 5AM Ventures and Chairman of the Board at ProLynx. Kush previously worked at Grace Science as a Member of Scientific Advisory Board. Kush M. Parmar attended the Princeton University.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Precede Biosciences	5AM Ventures	—	Series B - Precede Biosciences	obfuscated obfuscation
obfuscated obfuscation	ProLynx	5AM Ventures	Yes	Series A - ProLynx	obfuscated obfuscation
obfuscated obfuscation	Ensoma	5AM Ventures	—	Venture Round - Ensoma	obfuscated obfuscation
obfuscated obfuscation	Precede Biosciences	5AM Ventures	Yes	Series A - Precede Biosciences	obfuscated obfuscation
obfuscated obfuscation	Ensoma	5AM Ventures	Yes	Series B - Ensoma	obfuscated obfuscation
obfuscated obfuscation	Ensoma	5AM Ventures	Yes	Series A - Ensoma	obfuscated obfuscation
obfuscated obfuscation	Vor Biopharma	5AM Ventures	—	Series B - Vor Biopharma	obfuscated obfuscation
obfuscated obfuscation	Akouos	5AM Ventures	—	Series B - Akouos	obfuscated obfuscation
obfuscated obfuscation	Cleave Therapeutics	5AM Ventures	Yes	Series C - Cleave Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Vor Biopharma	5AM Ventures	Yes	Series A - Vor Biopharma	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Kush Parmar

has

current jobs as

Co-Founder

Immuneel Therapeutics

and

Managing Partner

5AM Ventures

. Additionally,

Kush Parmar

has had

past job as the

Founding CEO

Homology Medicines

Immuneel Therapeutics Co-FounderJul 2019
5AM Ventures Managing PartnerDec 17, 2015

Organization Name	Title At Company	Start Date	End Date
Homology Medicines	Founding CEO	Dec 2015	Apr 2023

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Kush Parmar

holds

board and advisor roles including

Chairman of the Board

ProLynx

Board Member

Ensoma

, and

Research Council Member

Penn Medicine

ProLynx Chairman of the BoardMay 2025
Ensoma Board MemberSep 2019
Penn Medicine Research Council MemberMar 2018
Entrada Therapeutics Chairman Of The Board Of DirectorSep 2016
Princeton University Advisory Council, Department of Molecular Biology2015
Audentes Therapeutics Member of the Board of DirectorsJul 2013

Organization Name	Title At Company	Start Date	End Date
Grace Science	Member of Scientific Advisory Board	Jun 2014	Dec 2025
Vor Biopharma	Chairman	Feb 2019	Dec 2022
Akouos	Board of Director	Sep 2017	Oct 2022
Arvinas	Board of Director	Jul 2013	Sep 2019
Achaogen	Board Observer	Nov 2010	Mar 2014
Envoy Therapeutics	Board Observer	May 2010	Nov 2012

Related Hubs

Hub Name	CB Rank (Hub)
United States Investors with Funds Raised in 2002	83,059
Post IPO Investors with Investments in United States	18,113
Seed Stage Investors with Investments in New England	5,746
Post IPO Investors with Investments in Massachusetts	50,843
Investors Active in New England (Top 10K)	1,210
Post IPO Investors with Investments in Greater Boston Area	51,805
Early Stage Venture Investors with Investments in Massachusetts	4,438
Post IPO Investors with Investments in East Coast	19,874
Post IPO Investors Venture Capital Investors	23,189
Venture Stage Investors with Investments in East Coast	5,192